NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 341 filers reported holding NEOGENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $963,090 | -24.2% | 78,300 | -1.0% | 0.35% | -23.3% |
| Q2 2023 | $1,271,137 | -4.6% | 79,100 | +3.4% | 0.45% | -11.7% |
| Q1 2023 | $1,331,865 | +89.2% | 76,500 | +0.4% | 0.51% | +75.6% |
| Q4 2022 | $704,088 | +17.0% | 76,200 | +9.0% | 0.29% | +14.6% |
| Q3 2022 | $602,000 | +5.1% | 69,900 | -0.5% | 0.25% | +2.8% |
| Q2 2022 | $573,000 | -27.9% | 70,285 | +7.4% | 0.25% | -11.5% |
| Q1 2022 | $795,000 | -59.1% | 65,445 | +14.9% | 0.28% | -56.1% |
| Q4 2021 | $1,943,000 | +32.8% | 56,945 | +87.8% | 0.64% | +26.4% |
| Q3 2021 | $1,463,000 | +23.0% | 30,330 | +15.2% | 0.50% | +28.0% |
| Q2 2021 | $1,189,000 | +5.7% | 26,330 | +12.9% | 0.39% | -5.1% |
| Q1 2021 | $1,125,000 | -6.2% | 23,330 | +4.7% | 0.41% | -12.5% |
| Q4 2020 | $1,200,000 | +158.1% | 22,280 | +76.8% | 0.47% | +115.0% |
| Q3 2020 | $465,000 | +114.3% | 12,600 | +80.0% | 0.22% | +105.6% |
| Q2 2020 | $217,000 | – | 7,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |